PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.80M | -28.38M | -24.76M | -19.49M | -14.29M |
| Total Depreciation and Amortization | 676.40K | 689.90K | 701.20K | 601.90K | 506.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.50K | 32.30K | -142.70K | 1.03M | 2.16M |
| Change in Net Operating Assets | -1.17M | -1.17M | -1.17M | -1.24M | -1.32M |
| Cash from Operations | -32.15M | -28.83M | -25.37M | -19.10M | -12.94M |
| Capital Expenditure | -515.50K | -361.40K | -200.80K | -307.90K | -417.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -515.50K | -361.40K | -200.80K | -307.90K | -417.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -332.00K | -313.20K | -294.40K | -279.60K | -264.80K |
| Issuance of Common Stock | 74.66M | 83.36M | 92.06M | 61.05M | 30.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.57M | -1.57M | -1.57M | -1.27M | -976.20K |
| Cash from Financing | 47.90M | 53.58M | 59.29M | 39.11M | 19.08M |
| Foreign Exchange rate Adjustments | 414.60K | 211.30K | 4.50K | -151.10K | -307.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.65M | 24.60M | 33.72M | 19.56M | 5.41M |